MLR 1017Alternative Names: MLR1017
Latest Information Update: 30 Nov 2015
Price : *
At a glance
- Originator Unknown
- Developer Melior Pharmaceuticals, Inc.
- Class Small molecules
- Mechanism of Action Undefined mechanism
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Preclinical Parkinson's disease
Most Recent Events
- 30 Nov 2015 Preclinical trials in Parkinson's disease in USA (unspecified route)